1. Home
  2. PRM vs LGND Comparison

PRM vs LGND Comparison

Compare PRM & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perimeter Solutions SA

PRM

Perimeter Solutions SA

HOLD

Current Price

$26.79

Market Cap

4.2B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$197.65

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRM
LGND
Founded
2018
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.9B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
PRM
LGND
Price
$26.79
$197.65
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$28.00
$243.50
AVG Volume (30 Days)
747.9K
229.4K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
0.76
EPS
0.52
2.49
Revenue
$636,343,000.00
$251,233,000.00
Revenue This Year
$15.59
$47.71
Revenue Next Year
$18.64
$9.77
P/E Ratio
$52.63
$79.59
Revenue Growth
19.12
64.83
52 Week Low
$8.76
$93.58
52 Week High
$29.88
$212.49

Technical Indicators

Market Signals
Indicator
PRM
LGND
Relative Strength Index (RSI) 40.82 49.89
Support Level $27.87 $188.13
Resistance Level $29.48 $207.06
Average True Range (ATR) 1.09 8.91
MACD -0.21 0.03
Stochastic Oscillator 1.03 60.63

Price Performance

Historical Comparison
PRM
LGND

About PRM Perimeter Solutions SA

Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: